- “It’s been over a week since the Equifax (EFX) data breach and the stock has beaten down by roughly 25%. Should we buy the dip? …Or is there still more pain to come?” – Anthony [00:46]
- “Can you quickly recommend a few online brokers that are capable of trading stocks directly on the TSX?” – John [12:11]
- “Is Advaxis (ADXS) dead? They have a premier drug in phase 3, with a couple others in early clinical stages, but the stock is in a free-fall as of late. What are Wall Street’s expectations?” – Chad [16:39]
- “Are the Eagles for real this year?” – Dale [33:34]
As always, thanks to everyone who participated!Ask me anything by emailing me at Frank@CurzioResearch (with “Frankly Speaking” in the subject line). You never know, your question may be the one I read on the next podcast! Good Investing, Frank Curzio
Stocks mentioned
Curzio Research publishes market commentary for informational and educational purposes. The opinions expressed and market conditions when the content is published may change. It is not personalized investment advice or an offer to buy or sell securities. Investing involves risk, including possible loss of principal. Do your own research and consult a qualified investment professional before making investment decisions.
